免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Hemoblock_S(处方);Hemoblock_S(OTC)

K号: K232216 · 2024-04-19

决定日期2024-04-19
产品代码QSY
决定实质等同

器械摘要

Hemoblock_S (Prescription); Hemoblock_S (OTC) is the device name listed in this FDA 510(k) record. The listed applicant is Incore Co., Ltd.. It received FDA 510(k) clearance on 2024-04-19 under 510(k) number K232216. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

常见问题

What is the Hemoblock_S (Prescription); Hemoblock_S (OTC)?

Hemoblock_S (Prescription); Hemoblock_S (OTC) is a medical device that received FDA 510(k) clearance on 2024-04-19. The listed applicant is Incore Co., Ltd.. The 510(k) number is K232216.

When did Hemoblock_S (Prescription); Hemoblock_S (OTC) receive FDA 510(k) clearance?

Hemoblock_S (Prescription); Hemoblock_S (OTC) received FDA 510(k) clearance on 2024-04-19, under 510(k) number K232216.

Who is the listed applicant for Hemoblock_S (Prescription); Hemoblock_S (OTC)?

The FDA 510(k) record lists Incore Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Hemoblock_S (Prescription); Hemoblock_S (OTC)?

The FDA product code for Hemoblock_S (Prescription); Hemoblock_S (OTC) is QSY.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Incore Co., Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:QSY)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑